Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.The Hackensack Meridian Center for Discovery and Innovation (CDI) has entered into a research alliance with Merck to explore drugs for the treatment of Covid-19.
Currently, the disease lacks an approved vaccine and broadly effective antiviral therapy, indicating the need for an effective drug to fight the ongoing pandemic.
As part of the research collaboration, Hackensack Meridian CDI and Merck will work to discover drug candidates that can help treat Covid-19.
Hackensack Meridian CDI will combine its expertise in academic drug discovery and viral pathogens analysis with Merck’s capabilities to discover and develop.